IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET

IM Cannabis (NASDAQ: IMCC) will report operational and financial results for the third quarter 2025, which ended September 30, 2025.

Rhea-AI Summary

IM Cannabis (NASDAQ: IMCC) will report operational and financial results for the third quarter 2025, which ended September 30, 2025.

The company said results will be released on Thursday, November 13, 2025, before the market opens. IM Cannabis operates in Israel and Germany.

Argus Nov 6 session

-0.75% close to close Open Argus

Details

News Market Reaction – IMCC

On Nov 6, the day this news came out, IMCC closed 0.75% below the previous close.

Data tracked by StockTitan Argus for the Nov 6 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO and GLIL YAM, Israel, Nov. 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended September 30, 2025, on Thursday, November 13, 2025, before the market opens.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company's focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-third-quarter-2025-financial-results-on-thursday-november-13th-at-900am-et-302607073.html

SOURCE IM Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will IM Cannabis (IMCC) report its Q3 2025 results?

IM Cannabis will report third quarter 2025 results on November 13, 2025, before the market opens.

What period does IM Cannabis's Q3 2025 report cover?

The results cover the quarter ended September 30, 2025.

What types of results will IM Cannabis (IMCC) release on November 13, 2025?

The company will report operational and financial results for Q3 2025.

Which markets does IM Cannabis operate in as noted in the Q3 2025 announcement?

The company operates in Israel and Germany.

Will the November 13, 2025 IMCC announcement include a webcast or investor presentation?

This notice states the reporting date and time; it does not provide webcast or presentation details.